Skip to main content
Year archive

OXFORD BIODYNAMICS PLC — 2023 filings

All 40 regulatory filings released by OXFORD BIODYNAMICS PLC (OBD) in 2023, sourced directly from the official regulator.

40 Filings
2023 Period
2023 filings (40)
Filing Released Lang
Notice of Results
Report Publication Announcement
2023-12-21 English
Director/PDMR Shareholding
Director's Dealing
2023-11-13 English
OBD strengths commercial leadership
Board/Management Information
2023-11-08 English
Holding(s) in Company
Major Shareholding Notification
2023-11-07 English
Holding(s) in Company
Director's Dealing
2023-11-06 English
Director/PDMR Shareholding
Director's Dealing
2023-11-03 English
PDMR Dealing / Grant of Share Options
Director's Dealing
2023-10-23 English
Director/PDMR Shareholding
Director's Dealing
2023-10-20 English
Bupa UK to cover EpiSwitch® CiRT for customers
Legal Proceedings Report
2023-10-18 English
Director/PDMR Shareholding
Director's Dealing
2023-10-06 English
Holding(s) in Company
Major Shareholding Notification
2023-10-03 English
OBD receives reimbursement code for PSE test
Regulatory Filings
2023-10-03 English
OBD launches 94% accurate PSE test in US and UK
Regulatory Filings
2023-09-26 English
Holding(s) in Company
Major Shareholding Notification
2023-09-07 English
Amendment: Director/PDMR Shareholding
Director's Dealing
2023-09-01 English
Holding(s) in Company
Major Shareholding Notification
2023-08-31 English
Holding(s) in Company
Major Shareholding Notification
2023-08-25 English
Holding(s) in Company
Major Shareholding Notification
2023-08-22 English
Holding(s) in Company
Major Shareholding Notification
2023-08-22 English
Result of General Meeting
Director's Dealing
2023-08-18 English
Holding(s) in Company
Major Shareholding Notification
2023-08-08 English
Results of PrimaryBid Offer
Share Issue/Capital Change
2023-08-04 English
Result of Placing and Subscription
Capital/Financing Update
2023-08-02 English
PrimaryBid Offer
Share Issue/Capital Change
2023-08-01 English
Proposed Fundraising
Share Issue/Capital Change
2023-08-01 English
Half-year Report
Interim / Quarterly Report H1 2023
2023-05-30 English
Notice of Interim Results and Investor Webinar
Report Publication Announcement
2023-05-16 English
CiRT expanded validation for ICI immunotherapies
Regulatory Filings
2023-05-15 English
US PACT Award for prognosis test for IOrelated HPD
Regulatory Filings
2023-05-02 English
Director/PDMR Shareholding
Director's Dealing
2023-04-18 English
Business update for PSE and CiRT tests
Regulatory Filings
2023-04-05 English
Result of AGM
AGM Information
2023-03-30 English
Holding(s) in Company
Major Shareholding Notification
2023-03-23 English
Holding(s) in Company
Major Shareholding Notification
2023-03-22 English
AIM Rule 17 Schedule 2(g) Update
Board/Management Information
2023-03-15 English
Publication of FY22 Annual Report
Report Publication Announcement
2023-03-03 English
PDMR Dealing
Director's Dealing
2023-02-23 English
OBD Prostate Screening EpiSwitch Blood Test Update
Regulatory Filings
2023-02-06 English
Director/PDMR Shareholding
Director's Dealing
2023-01-27 English
Preliminary Results and Notice of AGM
Earnings Release FY 2022
2023-01-24 English